Skip to main content

Table 3 Number of cats with clinical signs associated with troglostrongylosis

From: Pilot study evaluating the efficacy of a topical formulation containing emodepside and praziquantel in the treatment of natural feline troglostrongylosis

Clinical signs

Group

Day 0

n (%)

Day 14

n (%)

Day 28

n (%)

Day 42

n (%)

Day 56

n (%)

Cough

T

3 (37.5)

1 (12.5)

1 (12.5)

0

0

C

0

1 (12.5)

1 (12.5)

1 (12.5)

0

Pale mucous membranes

T

1 (12.5)

1 (12.5)

0

0

0

C

0

0

1 (12.5)

2 (25.0)

0

Hyperthermia

T

0

0

0

0

0

C

0

0

0

2 (25.0)

0

Ocular-nasal discharge

T

2 (25.0)

1 (12.5)

1 (12.5)

0

0

C

1 (12.5)

2 (25.0)

2 (25.0)

3 (37.5)

1 (12.5)

Tachypnoea

T

2 (25.0)

3 (37.5)

1 (12.5)

0

0

C

1 (12.5)

2 (25.0)

2 (25.0)

3 (37.5)

0

Dyspnoea

T

3 (37.5)

1 (12.5)

1 (12.5)

0

0

C

0

1 (12.5)

1 (12.5)

3 (37.5)

0

Abnormal breath sounds on lung auscultation

T

4 (50.0)

2 (25.0)

1 (12.5)

0

0

C

0

0

1 (12.5)

1 (12.5)

0

No. of cats with at least 1 sign

T

5 (62.5)

3 (37.5)

2 (25.0)

0

0

C

2 (25.0)

3 (37.5)

3 (37.5)

3 (37.5)

1 (12.5)

  1. Note: Cats of Group T (n = 8); cats of Group C (n = 8)